TMEM167B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.81980000355264E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.161140E-04 |
Normal-vs-Stage2 |
3.150500E-02 |
Normal-vs-Stage3 |
1.23119999750898E-08 |
Normal-vs-Stage4 |
2.6783999462765E-09 |
Stage1-vs-Stage2 |
9.535600E-01 |
Stage1-vs-Stage3 |
8.415200E-03 |
Stage1-vs-Stage4 |
5.115500E-03 |
Stage2-vs-Stage3 |
1.755770E-01 |
Stage2-vs-Stage4 |
1.165580E-01 |
Stage3-vs-Stage4 |
7.214000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.13040000272147E-08 |
Normal-vs-AfricanAmerican |
5.43530000007841E-07 |
Normal-vs-Asian |
3.191600E-01 |
Caucasian-vs-AfricanAmerican |
2.190600E-01 |
Caucasian-vs-Asian |
4.376600E-01 |
AfricanAmerican-vs-Asian |
1.724810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.92859999981599E-08 |
Normal-vs-Female |
2.21489999996383E-06 |
Male-vs-Female |
5.678600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.059400E-03 |
Normal-vs-Age(41-60Yrs) |
2.48059999999883E-05 |
Normal-vs-Age(61-80Yrs) |
4.89989999685747E-08 |
Normal-vs-Age(81-100Yrs) |
1.98026000000073E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.009200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.229600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.096600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.353850E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.517800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.965200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.517600E-01 |
Normal-vs-Grade 2 |
2.383500E-03 |
Normal-vs-Grade 3 |
5.74339464876061E-11 |
Normal-vs-Grade 4 |
5.3069992844712E-11 |
Grade 1-vs-Grade 2 |
3.922000E-01 |
Grade 1-vs-Grade 3 |
4.577200E-03 |
Grade 1-vs-Grade 4 |
7.190900E-04 |
Grade 2-vs-Grade 3 |
9.89380000000484E-05 |
Grade 2-vs-Grade 4 |
1.5094999999965E-05 |
Grade 3-vs-Grade 4 |
1.246780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.381700E-03 |
Normal-vs-ccB subtype |
1.10269999797907E-08 |
ccA subtype-vs-ccB subtype |
7.372500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.29110000002264E-06 |
Normal-vs-N1 |
1.142070E-03 |
N0-vs-N1 |
4.228600E-01 |
|
|